We have partnered with Oncolyze at a critical time in the company’s growth, as it moves from a stealth-mode discovery stage biotech to raising a Series A to advance its lead asset towards IND filing. TNG Creative has built a strong interest in the technology behind this innovative company. We have taken an equity position in Oncolyze and rolled up our sleeves to provide the company with an outstanding identity, a story that resonates with investors and potential partners, and commercial expertise via a suite of services across Strategy + Creative.
New York City, NY
Oncolyze is not just a client, but one of our portfolio companies. It is a perfect example of TNG’s unique and flexible engagement model aimed at enabling early stage biotechs to flourish even when limited by funding.
With Oncolozye, we have rolled up our sleeves and become part of the executive management team. We have built the marketing content from the ground up to tell a tantalizing story, raise awareness of a novel mechanism of action and ultimately excite investors and potential partners. Our creative team has led the development of a logo, stationary, a responsive website, a corporate presentation and a series of multichannel materials to reinforce that brand identity and support a Series A capital raise.
2019: Branding | Identity | Investor Relations | Product Planning | Content Building | Website | Executive Management